Thyroid hormones are essential for good health and are also critically important for fetal and neonatal brain development. They are secreted in two forms, (T4) and 3,5,3'-triiodothyronine (T3). T3 regulates the transcription of many genes. T4, in contrast, is essentially inactive for genomic processes unless converted to T3. This process, termed peripheral conversion, is controlled by at least two distinct enzymes, the Type I and the Type II 5'-deiodinases (5'D-I and 5'D-II). Primary thyroid dysfunction is the major cause of thyroid insufficiency and thyroid hormone excess. it is now apparent that peripheral deiodination of T4 to generate T3 plays a major role not only in regulating the overall supply of T3 but also in selectively modulating T3 concentrations within distinct Organs. Two recent discoveries have focused renewed attention on the extrathyroidal events regulating the availability of thyroid hormones to peripheral tissues. First, 5'D-I, considered to be the major enzyme responsible for peripheral conversion to generate plasma T3 from secreted T4, is a selenium requiring enzyme. Second, transthyretin (TTR) in the cerebrospinal fluid, synthesized in the choroid plexus, constitutes a specialized system for transport of T4, but not T3, to the brain. The studies proposed in this grant will define the importance of the 5'D-I selenoprotein to the generation and clearance of plasma iodothyronines, particularly T3, and explore the consequences of selenium deficiency on neonatal thyroid homeostasis and thyroid hormone dependent brain maturation. We will also attempt to determine the contributions of de novo T3 synthesis and thyroid 5'D-deiodination of T4 to generate T3 to the overall secretion of T3 from the thyroid. These studies will use selenium deficiency, which impairs 5'D-I activity in liver and kidney but not in the thyroid, and an analog of PTU, which does not affect thyroid hormone synthesis but does inhibit 5'D-I activity in liver, kidney and thyroid. Studies will also be performed to establish the role of cerebrospinal fluid TTR in the transport and regulation of thyroid hormone dependent processes in the brain.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK018919-23
Application #
2015984
Study Section
Endocrinology Study Section (END)
Program Officer
Linder, Barbara
Project Start
1978-12-01
Project End
1997-11-30
Budget Start
1996-12-01
Budget End
1997-11-30
Support Year
23
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Massachusetts Medical School Worcester
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
660735098
City
Worcester
State
MA
Country
United States
Zip Code
01655
Eng, P H; Cardona, G R; Previti, M C et al. (2001) Regulation of the sodium iodide symporter by iodide in FRTL-5 cells. Eur J Endocrinol 144:139-44
Marqusee, E; Braverman, L E; Lawrence, J E et al. (2000) The effect of droloxifene and estrogen on thyroid function in postmenopausal women. J Clin Endocrinol Metab 85:4407-10
Lawrence, J E; Lamm, S H; Pino, S et al. (2000) The effect of short-term low-dose perchlorate on various aspects of thyroid function. Thyroid 10:659-63
Bluher, M; Krohn, K; Wallaschofski, H et al. (1999) Cytokine gene expression in autoimmune thyroiditis in BioBreeding/Worcester rats. Thyroid 9:1049-55
Eng, P H; Cardona, G R; Fang, S L et al. (1999) Escape from the acute Wolff-Chaikoff effect is associated with a decrease in thyroid sodium/iodide symporter messenger ribonucleic acid and protein. Endocrinology 140:3404-10
Colzani, R M; Alex, S; Dunn, A D et al. (1999) The oral administration of human thyroglobulin does not affect the incidence of lymphocytic thyroiditis in the biobreeding Worcester rat. Thyroid 9:831-5
Tang, K T; Yang, H J; Choo, K B et al. (1999) A point mutation in the albumin gene in a Chinese patient with familial dysalbuminemic hyperthyroxinemia. Eur J Endocrinol 141:374-8
Roti, E; Gardini, E; Magotti, M G et al. (1999) Are thyroid function tests too frequently and inappropriately requested? J Endocrinol Invest 22:184-90
Minelli, R; Braverman, L E; Valli, M A et al. (1999) Recombinant interferon alpha (rIFN-alpha) does not potentiate the effect of iodine excess on the development of thyroid abnormalities in patients with HCV chronic active hepatitis. Clin Endocrinol (Oxf) 50:95-100
Bluher, M; Krohn, K; Wallaschofski, H et al. (1999) Fas and Fas ligand gene expression in autoimmune thyroiditis in BB/W rats. Eur J Endocrinol 141:506-11

Showing the most recent 10 out of 92 publications